Clinical Trials Directory

Trials / Completed

CompletedNCT02078232

Comparison of Two Needles (19G Flex Versus 22G Standard) for Pancreatic Solid Tumors Diagnosis

Randomized, Comparative Study of 19G Flex Versus 22G Standard Needles for Pancreatic Solid Tumors Diagnosis.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
124 (actual)
Sponsor
French Society of Digestive Endoscopy · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the diagnostic gain between 22G standard needle vs 19G Flex needles transduodenal punctures of masses of the pancreatic head.

Detailed description

The negative predictive value of fine needle aspiration under ultrasound endoscopy (EUS-FNA) for the diagnosis of solid pancreatic masses is about 70 - 80 % with the 22G standard needle. Pancreatic adenocarcinoma is known to have a severe prognosis and a low rate of survival even after curative surgery. The study of pancreatic solid tumors is one the main diagnostic problem present in the investigators daily practice. In most of non operated patients, EUS-FNA is the sole possibility to confirm the diagnosis of malignancy which is required to initiate chemotherapy and/or radiotherapy. To improve the performances of the EUS-FNA, new needles are now disposable either with a cutting window design (EchoTip ProCore-COOK Medical) or flexible 19G needle (19G Expect Flex - Boston-Scientific). The goal is to obtain more tissue material with the possibility of a histologic study without increasing the risk of the puncture which is very low (complications rate \< 1%). The problem concerns the lesion of the head of the pancreas requiring a trans-duodenal access for the puncture . In this position, the needle is very difficult to push out the operator channel and, in some cases, the puncture is quite impossible with stiff needles as "ProCore" or standard 19G. Thus, the interest of flexible 19G needle is to be used in difficult technical cases as transduodenal access for head pancreatic tumors, with a good safety and more efficacy than 22G needles.

Conditions

Interventions

TypeNameDescription
DEVICEpuncture of head of pancreaspuncture of head of pancreatic solid mass with fine needle aspiration under endoscopic ultrasonographic control. randomization: puncture with either 22G needle or 19G flex needle
DEVICEpuncture of head of pancreaspuncture of head of pancreatic solid mass with fine needle aspiration under endoscopic ultrasonographic control. randomization: puncture with either 22G needle or 19G flex needle

Timeline

Start date
2013-04-01
Primary completion
2016-07-06
Completion
2017-01-23
First posted
2014-03-05
Last updated
2017-04-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02078232. Inclusion in this directory is not an endorsement.